ISCO - International School of Clinical Oncology
S

What Is New in Treatment of Soft Tissue and Bone Sarcoma

By ISCO - International School of Clinical Oncology FEATURING Silvia Stacchiotti
By ISCO - International School of Clinical Oncology FEATURING Silvia Stacchiotti
133 views
February 6, 2024
1 Comment
Login to view comments. Click here to Login

Related Content

AUTOPLAY
13:04
Douglas Beall

Spinal Tumor Ablation and Vertebral Augmentation for Treatment of Pa…

27:04
Fengting Yan

Cancer Screening Molecular Tools

07:27
Jason Levy

Opus One: Final Results - RFA in Axial Skeleton

22:07
Total Health

2024 Update in Sarcomas

Feat. D. Portnoy
10:41
Francesco Massari

Treatment Approaches in Bone Metastases Pain Management

18:46
OncoAlert

Systemic Therapies for Uterine Leiomyosarcoma

Feat. I. Ray-Coquard
19:40
Warren Chow

Gastrointestinal Stromal Tumors (GIST) and Resistance Mutations

11:17
Jack William Jennings

NCCN Guidelines on Utilizing Radio-Frequency Ablation to Treat Metas…

15:45
i3 Health

Multidisciplinary Management of Advanced Soft Tissue Sarcoma

Feat. S. Patel, B. Ruben, K. Polson
10:55
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Novel Combinations in Sarcomas"

Feat. R. Jones
18:44
2023 West Oncology Conference

2023 West Oncology Conference: Soft Tissue Sarcoma Updates

Feat. B. Van Tine
09:02
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Phase II Basket Trial of Dual Anti-CTLA…

Feat. Y. Chae
07:29
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Randomized Phase 2 Trial in Metastatic So…

Feat. B. Van Tine
12:08
University of Miami Sylvester Comprehensive Cancer Center

Active Surveillance vs. Active Treatment for Desmoid Tumor: An Exper…

Feat. G. D'Amato
56:31
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Fred Hutchinson Cancer Center Sarcoma Updates

Feat. M. Wagner
10:48
Insights from 2024 ASCO® GI Annual Meeting

INSIGHT: A Phase 3 Study of Ripretinib vs. Sunitinib in Pts With Adv…

Feat. J. Zalcberg
33:54
Yale Cancer Center

Osteolytic Skeletal Metastases: AORIF as a New Strategy for Enhanced…

Feat. F. Lee
13:53
Robin Jones

Desmoid Tumors: Who, When, and How to Treat?

09:01
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Results From the MEDISARC Phase II Study o…

Feat. V. Grünwald
10:40
Joana Monteiro

From Diagnosis to Treatment of Bone Metastases in Solid Tumors